SEC Form 4 · accession 0001179110-18-011046

ABBOTT LABORATORIES · ABT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Jaime Contreras

Officer — Senior Vice President

Period of report

Aug 29, 2018

Accepted (ET)

Aug 31, 2018 · 5:04 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000001800

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common shares without par value	Aug 29, 2018	M	59,800	$34.94	A	110,236	D
Common shares without par value	Aug 29, 2018	M	112,668	$39.12	A	222,904	D
Common shares without par value	Aug 29, 2018	S	2,300	$66.64	D	220,604	D
Common shares without par value	Aug 29, 2018	S	699	$66.645	D	219,905	D
Common shares without par value	Aug 29, 2018	S	2,100	$66.65	D	217,805	D
Common shares without par value	Aug 29, 2018	S	2,500	$66.655	D	215,305	D
Common shares without par value	Aug 29, 2018	S	1,501	$66.66	D	213,804	D
Common shares without par value	Aug 29, 2018	S	2,400	$66.665	D	211,404	D
Common shares without par value	Aug 29, 2018	S	600	$66.67	D	210,804	D
Common shares without par value	Aug 29, 2018	S	1,300	$66.675	D	209,504	D
Common shares without par value	Aug 29, 2018	S	1,500	$66.68	D	208,004	D
Common shares without par value	Aug 29, 2018	S	2,300	$66.685	D	205,704	D
Common shares without par value	Aug 29, 2018	S	600	$66.69	D	205,104	D
Common shares without par value	Aug 29, 2018	S	800	$66.695	D	204,304	D
Common shares without par value	Aug 29, 2018	S	1,900	$66.70	D	202,404	D
Common shares without par value	Aug 29, 2018	S	110	$66.705	D	202,294	D
Common shares without par value	Aug 29, 2018	S	900	$66.71	D	201,394	D
Common shares without par value	Aug 29, 2018	S	2,200	$66.715	D	199,194	D
Common shares without par value	Aug 29, 2018	S	1,000	$66.72	D	198,194	D
Common shares without par value	Aug 29, 2018	S	1,400	$66.73	D	196,794	D
Common shares without par value	Aug 29, 2018	S	500	$66.735	D	196,294	D
Common shares without par value	Aug 29, 2018	S	1,000	$66.74	D	195,294	D
Common shares without par value	Aug 29, 2018	S	1,900	$66.745	D	193,394	D
Common shares without par value	Aug 29, 2018	S	1,400	$66.75	D	191,994	D
Common shares without par value	Aug 29, 2018	S	100	$66.755	D	191,894	D
Common shares without par value	Aug 29, 2018	S	2,100	$66.76	D	189,794	D
Common shares without par value	Aug 29, 2018	S	690	$66.765	D	189,104	D
Common shares without par value	Aug 29, 2018	S	58,993	$66.77	D	130,111	D
Common shares without par value	Aug 29, 2018	S	800	$66.775	D	129,311	D
Common shares without par value	Aug 29, 2018	S	2,200	$66.78	D	127,111	D

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Option (right to buy)^F1	$34.94	Aug 29, 2018	M	59,800	D	Feb 15, 2016	Feb 14, 2023	Common shares	59,800	0	D
Option (right to buy)^F1	$39.12	Aug 29, 2018	M	112,668	D	Feb 21, 2017	Feb 20, 2024	Common shares	112,668	0	D

Explanation of responses

F1Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.

Remarks

These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c). Form 1 of 2.